Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner.

Antiviral research - 1 Aug 2016

Lee Myungeun, Yang Jaewon, Park Sanghyun, Jo Eunji, Kim Hee-Young, Bae Yong-Soo, Windisch Marc P

Abstract excerpt

Hepatitis C virus (HCV) is considered a major public health concern worldwide. Despite recent advances in curing chronic hepatitis C, unmet medical needs still remain, especially due to the high economic burden of therapies. Accordingly, our study aimed to identify affordable novel HCV inhibitors by screening of natural product compound libraries. We identified micrococcin P1, a macrocyclic peptide antibiotic,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteriocins
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Synergism

Share to Hepatitis C

Share to Peptides

Share to Virus Internalization

Share to Virus Release

Share to Virus Replication

Source

Identifiers

PMID: 27387825
DOI: 10.1016/j.antiviral.2016.07.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner.PMID 27387825Read ↗

A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific MannerSemantic proximity Read ↗

P2-quinazolinones and bis-macrocycles as new templates for next-generation hepatitis C virus NS3/4a protease inhibitors: discovery of MK-2748 and MK-6325.Semantic proximity Read ↗

Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection.Semantic proximity Read ↗

MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants.Semantic proximity Read ↗

Novel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell culture.Semantic proximity Read ↗

Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein.Semantic proximity Read ↗

Discovery of MK-8831, A Novel Spiro-Proline Macrocycle as a Pan-Genotypic HCV-NS3/4a Protease InhibitorSemantic proximity Read ↗

High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.Semantic proximity Read ↗

A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.Semantic proximity Read ↗

Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry.Semantic proximity Read ↗

Development of potent macrocyclic inhibitors of genotype 3a HCV NS3/4A protease.Semantic proximity Read ↗

Chemical genetics-based development of small molecules targeting hepatitis C virus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.